II/III级肥胖使下肢旁路术后伤口并发症风险翻倍
基于BMC2注册数据纳入7676例择期下肢旁路术患者,按BMI分五组,以健康体重为参照行贝叶斯混合效应逻辑回归。II/III级肥胖患者30天和1年伤口并发症风险显著升高,但1年大截肢风险反而降低,30天及1年主要不良心血管事件无差异。
要点
- II/III级肥胖使30天伤口并发症风险升高(OR 1.728),1年风险亦升高(OR 1.881)。
- 肥胖患者1年大截肢风险降低,II/III级肥胖OR 0.58。
- 各BMI组间30天及1年主要不良心血管事件无差异。
核心结论
- BMI与下肢旁路术后伤口并发症呈正相关,II/III级肥胖风险约翻倍。
- 肥胖并未增加1年大截肢风险,反而降低,且不增加主要不良心血管事件。
研究设计与样本
- 回顾性队列研究,数据来自Blue Cross Blue Shield Michigan心血管联盟(BMC2)注册库。
- 排除<18岁、院内死亡、数据缺失、急诊手术及腘动脉陷迫综合征或创伤者。
主要发现
- 以健康体重为参照,II/III级肥胖30天伤口并发症OR 1.728(95%CI 1.31-2.279),1年OR 1.881(95%CI 1.457-2.431)。
- 1年大截肢:I级肥胖OR 0.74(95%CI 0.55-1.00),II/III级肥胖OR 0.58(95%CI 0.39-0.86)。
- 30天死亡:超重OR 0.356(95%CI 0.167-0.725),I级肥胖OR 0.38(95%CI 0.147-0.829)。
- 1年死亡:I级肥胖OR 0.727(95%CI 0.537-0.981)。
- 各BMI组30天及1年主要不良心血管事件无差异。
关键数值与推荐
- BMI分类:低体重<18.5,健康体重18.5-<25,超重25-<30,I级肥胖30-<35,II/III级肥胖≥35。
- 贝叶斯模型以95%可信区间不包含1.00为显著。
临床怎么用
- 对II/III级肥胖患者行择期下肢旁路术前,应告知伤口并发症风险升高。
- 肥胖不应作为排除择期下肢旁路术的绝对依据,因其大截肢风险更低且心血管事件无增加。
局限性
- 数据来自单一州注册库,非教学医院数据稀缺可能影响外推。
- 回顾性设计,存在未测量混杂可能。
- 仅纳入择期手术,排除了急诊及创伤等病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although lower extremity bypass (LEB) may be the only viable option for limb salvage in selected patients with chronic limb-threatening ischemia, it carries significant postprocedural risks. Previous studies on the impact of body mass index (BMI) and LEB typically extrapolated data from national databases, which may be skewed by data abstracted from hospitals with vascular residency or fellowship training programs. The scarcity of data from nonteaching hospitals does not permit a comprehensive picture of outcomes. METHODS: We queried the Blue Cross Blue Shield Michigan Cardiovascular Consortium (BMC2) registry data to identify patients who underwent elective LEB. Cases with patients younger than 18 years, in-hospital death, missing data, emergent procedures, or LEB for popliteal artery entrapment syndrome or trauma were excluded. Patient demographic characteristics are classified into five BMI categories: underweight (BMI < 18.5), healthy weight (BMI ≥ 18.5 and <25), overweight (BMI ≥ 25 and <30), class I obesity (BMI ≥ 30 and <35), and class II or III obesity (BMI ≥ 35). Primary outcomes included 30-day and 1-year wound complications and amputation. Secondary outcomes included major adverse cardiac events and their constituent elements (mortality, myocardial infarction, and stroke). Unadjusted differences were tested using F-tests from one-way analyses of variance, Kruskal-Wallis tests, or χ2 tests, depending on the variable type and distribution. These tests, when significant, were followed by Bayesian mixed-effects logistic regression models to control for site, demographic, and comorbidity differences between exposure groups. Bayesian models are interpreted as significant if the 95% credible intervals (CIs) around the odds ratios (ORs) do not include 1.00. RESULTS: Between January 2016 and December 2024, a total of 7676 patients underwent elective LEB, with a mean age of 67 years. The study cohort was divided into five different BMI categories as follows: underweight (n = 297; 3.9%), healthy weight (n = 2325; 30.3%), overweight (n = 2639; 34.4%), class I obesity (n = 1528; 19.9%), class II or III obesity (n = 887; 11.5%). Using healthy weight patients as reference, adjusted analysis of primary outcomes demonstrated that patients with class II/III obesity had significantly higher odds of 30-day and 1-year wound complications (30-day: OR, 1.728; 95% CI, 1.31-2.279; 1-year: OR, 1.881; 95% CI, 1.457-2.431). Interestingly, obese patients demonstrated lower odds of 1-year major amputations (class I obesity: OR, 0.74; 95% CI, 0.55-1.00; class II/III obesity: OR, 0.58; 95% CI, 0.39-0.86). For secondary outcomes, patients with overweight and class I obesity had lower odds of 30-day mortality (overweight: OR, 0.356; 95% CI, 0.167-0.725; class I obesity: OR, 0.38; 95% CI, 0.147-0.829). Patients with class I obesity also had lower odds of 1-year mortality (OR, 0.727; 95% CI, 0.537-0.981). There were no differences in 30-day and 1-year major adverse cardiac events across all BMI cohorts. CONCLUSIONS: The positive linear relationship between BMI and post-LEB wound complications may not preclude obese chronic limb-threatening ischemia patients from elective LEB. Nevertheless, patients with higher BMI should be counseled on higher risks of wound complications after LEB.
引用
- Djapri G, Constantinou C, Kazmers A, et al. Having class II/III obesity significantly increases risks of wound complications following lower extremity bypass by twofold. J Vasc Surg. 2026. PMID: 42607822. doi:10.1016/j.jvs.2026.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。